Paolo Ghia, MD, PhD, discusses the CAPTIVATE trial in chronic lymphocytic leukemia/small lymphocytic lymphoma, and what ...

Marlise R. Luskin, MD, MSCE, discussed treatment options for blastic plasmacytoid dendritic cell neoplasm (BPDCN), a rare and challenging disease.

GLP-1RAs were not associated with an increased risk for thyroid cancer relative to DPP-4 inhibitor use among an international cohort.

In addition, although we attempted to control for patient-mix differences between the 2 physician cohorts using a robust set of patient-level characteristics, some residual differences may remain ...

At cohort entry, we excluded patients who were less than 18 years of age, had less than one year of medical history in the database, had no diagnosis of type 2 diabetes, had contraindications such as ...

The patient received proton beam radiation therapy and underwent repeat resection of residual/recurrent neoplasm. Patient was not treated with temozolomide as MGMT promoter methylation in the tumour ...

When necessary, this was followed by the adjusted residual post-test, which allows for the identification ... 56.4% had a positive family history of neoplasia, and 30% were not in menopause.

A recently developed and validated risk prediction scoring system predicted the likelihood of detecting advanced colorectal neoplasia in adults < 45 years of age based on tobacco use history ...

The advent of effective antiretroviral therapy (ART) has increased the lifespan of many people living with HIV. As a result, ...

Use the residual income model to value firms that don't pay dividends or have positive free cash flow. This model adjusts future earnings by accounting for equity costs, focusing on economic ...